In general, studies of sildenafil (a phosphodiesterase type 5 inhibitor) have been inconsistent and mostly show sildenafil to be ineffective in women; only one small study showed a small reduction in adverse sexual effects in premenopausal women with SSRI-associated sexual dysfunction (4).